Population-scale sequencing resolves determinants of persistent EBV DNA.

Saved in:
Bibliographic Details
Title: Population-scale sequencing resolves determinants of persistent EBV DNA.
Authors: Nyeo SS; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Program in Computational Biology, Weill Cornell School of Medicine, New York, NY, USA., Cumming EM; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Burren OS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pagadala MS; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gutierrez JC; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ali TA; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Program in Computational Biology, Weill Cornell School of Medicine, New York, NY, USA., Kida LC; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen Y; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA., Chu H; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Program in Computational Biology, Weill Cornell School of Medicine, New York, NY, USA., Hu F; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Zou XZ; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hollis B; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Fabre MA; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., MacArthur S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Wang Q; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ludwig LS; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany., Dey KK; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. slav.petrovski@astrazeneca.com., Dhindsa RS; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA. Ryan.Dhindsa@bcm.edu.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. Ryan.Dhindsa@bcm.edu.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. Ryan.Dhindsa@bcm.edu., Lareau CA; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lareauc@mskcc.org.
Source: Nature [Nature] 2026 Feb; Vol. 650 (8102), pp. 664-672. Date of Electronic Publication: 2026 Jan 28.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-025-10020-2